Abbott Laboratories (TSX:ABT)
Canada · Delayed Price · Currency is CAD 18.52
+0.32 (1.76%)
Oct 30, 2026, 3:49 PM EDT
Abbott Laboratories Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 48,229 | 44,328 | 41,950 | 40,109 | 43,653 | 43,075 |
Revenue Growth | 10.00% | 5.67% | 4.59% | -8.12% | 1.34% | 24.46% |
Gross Profit Gross Profit Growth | 27,531 | 25,118 | 23,306 | 22,190 | 24,570 | 24,995 |
Operating Income Operating Income Growth | 7,982 | 8,917 | 7,496 | 7,220 | 9,113 | 9,204 |
Net Income Net Income Growth | 4,677 | 6,500 | 13,400 | 5,700 | 6,905 | 7,042 |
Earnings Per Share EPS Growth | 2.69 | 3.72 | 7.64 | 3.26 | 3.91 | 3.94 |
EPS Growth | -66.24% | -51.31% | 134.36% | -16.62% | -0.76% | 57.38% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Established Pharmaceutical Products Established Pharmaceutical Products Growth | 5,921 | 5,536 | 5,194 | 5,066 | 4,912 | 4,718 |
Nutritionals Nutritionals Growth | 8,363 | 8,451 | 8,413 | 8,154 | 7,459 | 8,294 |
Diagnostics Diagnostics Growth | 11,034 | 8,937 | 9,341 | 9,988 | 16,469 | 15,526 |
Medical Devices Medical Devices Growth | 22,893 | 21,387 | 18,986 | 16,887 | 14,802 | 14,485 |
Other Segment Other Segment Growth | 18 | 17 | 16 | 14 | 11 | 52 |
Revenue (Total) Revenue (Total) Growth | 48,229 | 44,328 | 41,950 | 40,109 | 43,653 | 43,075 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 5,603 | 8,939 | 7,968 | 7,279 | 10,170 | 10,249 |
Total Debt Total Debt Growth | 32,720 | 14,136 | 15,326 | 15,968 | 17,966 | 19,251 |
Net Cash (Debt) Net Cash Growth | -27,117 | -5,197 | -7,358 | -8,689 | -7,796 | -9,002 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -15.55 | -2.97 | -4.21 | -4.97 | -4.42 | -5.03 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | - | 9,566 | 8,558 | 7,261 | 9,581 | 10,533 |
Capital Expenditures CapEx Growth | - | -2,171 | -2,207 | -2,202 | -1,777 | -1,885 |
Free Cash Flow Free Cash Flow Growth | - | 7,395 | 6,351 | 5,059 | 7,804 | 8,648 |
Free Cash Flow Growth | - | 16.44% | 25.54% | -35.17% | -9.76% | 51.08% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 57.08% | 56.66% | 55.56% | 55.32% | 56.28% | 58.03% |
Operating Margin | 16.55% | 20.12% | 17.87% | 18.00% | 20.88% | 21.37% |
Pretax Margin | 13.61% | 19.10% | 16.72% | 16.61% | 19.03% | 19.06% |
Profit Margin | 9.70% | 14.66% | 31.94% | 14.21% | 15.82% | 16.35% |
FCF Margin | - | 16.68% | 15.14% | 12.61% | 17.88% | 20.08% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.437 | 2.400 | 2.240 | 2.080 | 1.920 | 1.820 |
Dividend Per Share Growth | 0% | 7.14% | 7.69% | 8.33% | 5.50% | 18.95% |
Dividend Yield | 2.36% | 1.91% | 1.98% | 1.89% | 1.74% | 1.33% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 39.47 | 33.52 | 14.64 | 33.52 | 27.72 | 34.28 |
P/FCF Ratio | 23.45 | 29.46 | 30.89 | 37.77 | 24.53 | 27.91 |
PS Ratio | 3.74 | 4.92 | 4.68 | 4.76 | 4.39 | 5.60 |